# MNX1

## Overview
The MNX1 gene encodes the motor neuron and pancreas homeobox 1 protein, a transcription factor that plays a pivotal role in the development of motor neurons and the pancreas. This protein is characterized by a homeodomain, which is crucial for its function in DNA binding and transcriptional regulation. As a transcription factor, MNX1 is involved in the repression of pan-neuronal genes, thereby maintaining motor neuron identity and function. It interacts with various co-repressors and motor neuron-inducing factors, highlighting its significance in neuronal specification and organization. Mutations in the MNX1 gene are associated with several clinical conditions, most notably Currarino syndrome, which underscores its importance in human developmental processes (Sun2021Homeobox; Merello2013Novel).

## Structure
The MNX1 gene encodes a transcription factor that plays a crucial role in the development of motor neurons and the pancreas. The protein consists of 401 amino acids and includes several key structural domains. One of the most significant features is the homeodomain, which spans residues 242 to 299. This domain is a highly conserved region that facilitates DNA binding, essential for the protein's function as a transcription factor (GarciaBarceló2009MNX1).

In addition to the homeodomain, MNX1 contains a polyalanine region, composed of residues 121 to 134. Polyalanine tracts are common in eukaryotic proteins and are typically encoded by imperfect trinucleotide repeats. These regions can influence the protein's structural stability and function (GarciaBarceló2009MNX1).

The MNX1 protein is subject to various mutations, including frameshift, missense, and nonsense mutations, which can impact its function and lead to conditions such as Currarino Syndrome. These mutations are often located before or within the homeodomain, affecting the protein's ability to bind DNA and regulate gene expression (Han2020Novel; Merello2013Novel). The presence of splice variants and post-translational modifications may further modulate the protein's activity and stability, although specific details on these aspects are not provided in the context.

## Function
The MNX1 gene encodes a homeobox transcription factor that plays a crucial role in the development and function of motor neurons. In healthy human cells, MNX1 is primarily active in the nucleus, where it binds to DNA to regulate transcriptional activity. It functions as a transcriptional repressor, restraining the expression of pan-neuronal genes to maintain the identity and function of motor neurons (Sun2021Homeobox).

MNX1 interacts with core motor neuron-inducing factors such as ISL1 and LHX3 on neuronal enhancers, suggesting its involvement in motor neuron specification (Sun2021Homeobox). It binds to thousands of conserved neuronal enhancers and housekeeping-like promoters, with a significant portion located within promoters, intronic, and intergenic regions (Sun2021Homeobox). The gene's regulatory role is highly specific, as evidenced by the alteration in expression of only a small fraction of genes upon MNX1 disruption (Sun2021Homeobox).

MNX1's function is mediated by its interaction with the Groucho co-repressor, which recruits histone deacetylases to mediate transcriptional repression (Sun2021Homeobox). This interaction is crucial for maintaining proper gene regulation in motor neurons, ensuring appropriate axonal projections and motor neuron organization (Sun2021Homeobox).

## Clinical Significance
Mutations in the MNX1 gene are primarily associated with Currarino syndrome (CS), a rare congenital disorder characterized by a triad of anorectal malformations, sacral bone defects, and presacral masses. These mutations are found in nearly all familial cases and about 30% of sporadic cases of CS (Merello2013Novel; Romano2021The). The MNX1 gene mutations include frameshift, nonsense, missense, and splice site variants, which can lead to haploinsufficiency and result in both complete and incomplete CS phenotypes (Han2020Novel; Merello2013Novel). 

The clinical presentation of CS is highly variable, even among patients with the same MNX1 mutation, suggesting the influence of other genetic factors or modifier genes (GarciaBarceló2009MNX1; Dworschak2021Currarino). Some individuals with MNX1 mutations may be asymptomatic or present with minimal symptoms, such as constipation (Dworschak2021Currarino). 

In addition to CS, certain MNX1 mutations have been linked to other conditions, such as permanent neonatal diabetes mellitus (PNDM) and severe neurological complications (Dworschak2021Currarino). The variability in phenotypes caused by MNX1 mutations underscores the complexity of its role in human development and disease.

## Interactions
MNX1, a transcription factor, participates in various interactions with proteins and nucleic acids that influence its regulatory functions. In glioma cells, MNX1 interacts with the TrkB gene, a tyrosine kinase receptor, by binding to its upstream regulatory region. This interaction activates TrkB expression, reducing cell adhesion and increasing survival in suspension, which contributes to tumor metastasis (Jiang2018MNX1).

In motor neurons, MNX1 acts as a transcriptional repressor by interacting with the Groucho co-repressor. This interaction recruits histone deacetylases (HDACs) to mediate transcriptional repression, restraining the expression of pan-neuronal genes (Sun2021Homeobox). MNX1 also colocalizes with core motor neuron-inducing factors ISL1 and LHX3 on neuronal enhancers, which are crucial for motor neuron specification (Sun2021Homeobox).

In intrahepatic cholangiocarcinoma, MNX1 is involved in the repression of the Hippo signaling pathway by upregulating Ajuba protein expression. MNX1 binds to the promoter region of Ajuba, facilitating its expression and promoting tumorigenesis (Li2020LncRNA). These interactions highlight MNX1's role in various cellular processes and its potential as a therapeutic target in different cancers.


## References


[1. (Li2020LncRNA) Fengwei Li, Qinjunjie Chen, Hui Xue, Lei Zhang, Kui Wang, and Feng Shen. Lncrna mnx1-as1 promotes progression of intrahepatic cholangiocarcinoma through the mnx1/hippo axis. Cell Death &amp; Disease, October 2020. URL: http://dx.doi.org/10.1038/s41419-020-03029-0, doi:10.1038/s41419-020-03029-0. This article has 22 citations.](https://doi.org/10.1038/s41419-020-03029-0)

[2. (Dworschak2021Currarino) Gabriel C. Dworschak, Heiko M. Reutter, and Michael Ludwig. Currarino syndrome: a comprehensive genetic review of a rare congenital disorder. Orphanet Journal of Rare Diseases, April 2021. URL: http://dx.doi.org/10.1186/s13023-021-01799-0, doi:10.1186/s13023-021-01799-0. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13023-021-01799-0)

[3. (Merello2013Novel) Elisa Merello, Patrizia De Marco, Marcello Ravegnani, Giovanna Riccipetitoni, Armando Cama, and Valeria Capra. Novel mnx1 mutations and clinical analysis of familial and sporadic currarino cases. European Journal of Medical Genetics, 56(12):648–654, December 2013. URL: http://dx.doi.org/10.1016/j.ejmg.2013.09.011, doi:10.1016/j.ejmg.2013.09.011. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmg.2013.09.011)

4. (Sun2021Homeobox) Homeobox transcription factor MNX1 is crucial for restraining the expression of pan-neuronal genes in motor neurons. This article has 4 citations.

[5. (Han2020Novel) Lu Han, Zhen Zhang, Hui Wang, Hui Song, Qing Gao, Yuchun Yan, Ran Tao, Ping Xiao, Long Li, Qian Jiang, and Qi Li. Novel mnx1 mutations and genotype–phenotype analysis of patients with currarino syndrome. Orphanet Journal of Rare Diseases, June 2020. URL: http://dx.doi.org/10.1186/s13023-020-01442-4, doi:10.1186/s13023-020-01442-4. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13023-020-01442-4)

[6. (GarciaBarceló2009MNX1) Maria-Mercè Garcia-Barceló, Vincent Chi-Hang Lui, Man-ting So, Xiaoping Miao, Thomas Yuk-yu Leon, Zhen-wei Yuan, Elly Sau-wai Ngan, Toufique Ehsan, Patrick Ho-yu Chung, Pek-lan Khong, Kenneth Kak-yuen Wong, and Paul Kwong-hang Tam. Mnx1 (hlxb9) mutations in currarino patients. Journal of Pediatric Surgery, 44(10):1892–1898, October 2009. URL: http://dx.doi.org/10.1016/j.jpedsurg.2009.03.039, doi:10.1016/j.jpedsurg.2009.03.039. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jpedsurg.2009.03.039)

[7. (Jiang2018MNX1) Lai Jiang, Shaojun Chen, Donggang Zhao, Jun Yan, Jiemin Chen, Chunlin Yang, and Gang Zheng. Mnx1 reduces sensitivity to anoikis by activating trkb in human glioma cells. Molecular Medicine Reports, July 2018. URL: http://dx.doi.org/10.3892/mmr.2018.9329, doi:10.3892/mmr.2018.9329. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2018.9329)

[8. (Romano2021The) Ferruccio Romano, Patrizia De Marco, Marzia Ognibene, Marco Di Duca, Simona Baldassari, Marco Pavanello, Gianluca Piatelli, Federico Zara, and Valeria Capra. The first case of mosaic <scp>mnx1</scp> mutation in an adult female with features of currarino syndrome. Birth Defects Research, 113(15):1161–1165, June 2021. URL: http://dx.doi.org/10.1002/bdr2.1936, doi:10.1002/bdr2.1936. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/bdr2.1936)